Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Immuno-Oncology Technology
|
September 23, 2024
Region of interest localization, tissue storage time, and antibody binding density-a technical note on the GeoMx® Digital Spatial Profiler
S Böning, F Schneider, A-K Huber, et al.
British Journal of Cancer
|
April 17, 1999
Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma
R Hoffmann, A Franzke, J Buer, et al.
Der Urologe. Ausg. A
|
December 16, 2014
[Structure of biobanks for urological research]
G Hatiboglu, J Huber, E Herpel, et al.
Journal of the National Cancer Institute
|
May 1, 1996
Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma
U Kunter, J Buer, M Probst, et al.
The American Journal of Surgical Pathology
|
June 23, 2001
Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia
J T Keating, A Cviko, S Riethdorf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2016
PARP inhibition in BRCA2-mutated prostate cancer
C Nientiedt, Y Tolstov, A-L Volckmar, et al.
Der Urologe. Ausg. A
|
March 12, 2015
[Intratumoral heterogeneity in renal cell carcinoma. Molecular basis and translational implications]
R Höfflin, W Roth, H Sültmann, et al.
British Journal of Haematology
|
August 1, 1997
Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma
M Probst-Kepper, A Schrader, J Buer, et al.
Oncogene
|
November 19, 2008
Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture
E E Hoskins, T A Morris, J M Higginbotham, et al.
Oncogene
|
September 13, 2016
Ecotropic viral integration site 1, a novel oncogene in prostate cancer
A Queisser, S Hagedorn, H Wang, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Immuno-Oncology Technology
|
September 23, 2024
Region of interest localization, tissue storage time, and antibody binding density-a technical note on the GeoMx® Digital Spatial Profiler
S Böning, F Schneider, A-K Huber, et al.
British Journal of Cancer
|
April 17, 1999
Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma
R Hoffmann, A Franzke, J Buer, et al.
Der Urologe. Ausg. A
|
December 16, 2014
[Structure of biobanks for urological research]
G Hatiboglu, J Huber, E Herpel, et al.
Journal of the National Cancer Institute
|
May 1, 1996
Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma
U Kunter, J Buer, M Probst, et al.
The American Journal of Surgical Pathology
|
June 23, 2001
Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia
J T Keating, A Cviko, S Riethdorf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2016
PARP inhibition in BRCA2-mutated prostate cancer
C Nientiedt, Y Tolstov, A-L Volckmar, et al.
Der Urologe. Ausg. A
|
March 12, 2015
[Intratumoral heterogeneity in renal cell carcinoma. Molecular basis and translational implications]
R Höfflin, W Roth, H Sültmann, et al.
British Journal of Haematology
|
August 1, 1997
Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma
M Probst-Kepper, A Schrader, J Buer, et al.
Oncogene
|
November 19, 2008
Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture
E E Hoskins, T A Morris, J M Higginbotham, et al.
Oncogene
|
September 13, 2016
Ecotropic viral integration site 1, a novel oncogene in prostate cancer
A Queisser, S Hagedorn, H Wang, et al.
Page
of 8